romiplostimthrombocytopeniaallogeneic bone marrow transplantationромиплостимтромбоцитопенияаллогенная трансплантация костного мозга1.1. Kim D., Sohn S., Jeon S. et al. Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD. Bone MarrowKim D., Sohn S., Jeon S. et al. Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD. Bone Marrow2.Transplant 2006;37:101–8.3.2. Bolwell B., Pohlman B., Sobecks R. et al. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 2004;33:419–23.Bolwell B., Pohlman B., Sobecks R. et al. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 2004;33:419–23.4.3. First L., Smith B., Lipton J. et al. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985;65:368–74.First L., Smith B., Lipton J. et al. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood 1985;65:368–74.5.4. Yamazaki R., Kuwana M., Mori T. et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased plateletYamazaki R., Kuwana M., Mori T. et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet6.turnover. Bone Marrow Transplant 2006;38:377–84.7.5. Hijyama K., Wada H., Shimura M. et al. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura? Idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1997;8(6):345–9.Hijyama K., Wada H., Shimura M. et al. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura? Idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1997;8(6):345–9.8.6. Usui K., Tahara T., Iki S. et al. Serum thrombopoietin level in various hematological diseases. Stem Cells 1996;14(5):558–65.Usui K., Tahara T., Iki S. et al. Serum thrombopoietin level in various hematological diseases. Stem Cells 1996;14(5):558–65.9.7. Aledort L., Hayward C., Chen M. et al. Prospective screening of 205 patients withITP, including diagnosis, serological markers and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombpoietin antibodies. Am J Hematol 2004;76(3):205–13.Aledort L., Hayward C., Chen M. et al. Prospective screening of 205 patients withITP, including diagnosis, serological markers and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombpoietin antibodies. Am J Hematol 2004;76(3):205–13.10.8. Keever-Taylor C., Klein J., Eastwood D. et al. Factors affecting neutrophil and platelet reconstitution following T celldepleted bone marrow transplantation: differential effects of growth factor type and role of CD34+ cell dose. Bone Marrow Transplant 2001;27:791–800.Keever-Taylor C., Klein J., Eastwood D. et al. Factors affecting neutrophil and platelet reconstitution following T celldepleted bone marrow transplantation: differential effects of growth factor type and role of CD34+ cell dose. Bone Marrow Transplant 2001;27:791–800.11.9. Singhal S., Powles R., Treleaven J. et al. A low CD34+ cell dose results in high mortality and poorer survival after blood or marrow stem cell transplantation fromHLA-identical siblings: should 2 × 10(6)Singhal S., Powles R., Treleaven J. et al. A low CD34+ cell dose results in high mortality and poorer survival after blood or marrow stem cell transplantation fromHLA-identical siblings: should 2 × 10(6)12.CD34+ cells/kg be considered the minimum threshold? Bone Marrow Transplant2000;26:489–96.13.10. Verdonck L., de Gast G., van Heugten H. et al. Cytomegalovirus infection causesdelayed platelet recovery after bone marrow transplantation. Blood 1991;78:844–8.Verdonck L., de Gast G., van Heugten H. et al. Cytomegalovirus infection causesdelayed platelet recovery after bone marrow transplantation. Blood 1991;78:844–8.14.11. Zhang X., Fu H., Xu L. et al. Prolonged thrombocytopenia following allogeneichematopoietic stem cell transplantation and ts association with a reduction in ploidy and an immaturation of megakaryocytic. Biol Blood Marrow Transplant 2011;17:274–80.Zhang X., Fu H., Xu L. et al. Prolonged thrombocytopenia following allogeneichematopoietic stem cell transplantation and ts association with a reduction in ploidy and an immaturation of megakaryocytic. Biol Blood Marrow Transplant 2011;17:274–80.15.12. Wang B., Nichol J., Sullivan J. et al. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther 2004;76:628–38.Wang B., Nichol J., Sullivan J. et al. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand. Clin Pharmacol Ther 2004;76:628–38.16.13. Bussel J., Kuter D., George R. et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006;255:1672–81.Bussel J., Kuter D., George R. et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006;255:1672–81.17.14. Steensma D. Hematopoetic growth factors in myelodysplastic syndromes. Semin Oncol 2011;38(5):635–47.Steensma D. Hematopoetic growth factors in myelodysplastic syndromes. Semin Oncol 2011;38(5):635–47.18.15. Panzer S. Eltrombopag in chronic idiopathic thrombocytopenic purpura and HCV-related thrombocytopenia. Drugs Today 2009;45(2):93–9.Panzer S. Eltrombopag in chronic idiopathic thrombocytopenic purpura and HCV-related thrombocytopenia. Drugs Today 2009;45(2):93–9.19.16. Bussel J., Kuter D., George J. et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006;335:1672–81.Bussel J., Kuter D., George J. et al. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006;335:1672–81.20.17. Gangatharan S., Cooney J. Persistent thrombocytopenia post auto-SCT for AML treated with romiplostim in a patient with HIV. Bone Marrow Transplant 2011;46(9):1280–1.Gangatharan S., Cooney J. Persistent thrombocytopenia post auto-SCT for AML treated with romiplostim in a patient with HIV. Bone Marrow Transplant 2011;46(9):1280–1.21.18. Beck J., Burke M., Tolar J. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim. Pediatr Blood Cancer 2010;54:490–1.Beck J., Burke M., Tolar J. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim. Pediatr Blood Cancer 2010;54:490–1.22.19. Rank A., Weigert O., Stermann H. Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle. Biologics: Targets &Rank A., Weigert O., Stermann H. Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principle. Biologics: Targets &23.Therapy 2010;4:139–45.